IXICO will be presenting on Tuesday 25 August at 1.30pm. The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet IXICO plc via the following link: https://www.investormeetcompany.com/ixico-plc/register-investor.
Investor Meet Company, is a new digital platform, where investors can go and express an interest for a webcast from a specific company, creating an opportunity for investors, no matter where they are based in the UK, to hear management speak.
Questions can be submitted pre-event to IXICO@walbrookpr.com or in real time during the presentation, via the "Ask a Question" function. Whilst the Company will not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.
ON Helix is fully committed to bring the insights and connections needed to understand innovation in translational research and support R&D companies in their current and future therapeutic and technology developments.
A core Keynote Programme with a mix of live streamed and pre-recorded insights from leading innovators and leaders combined with parallel pre-recorded streams focussing on company showcasing, senior executing interviews, international sessions, business workshops and learning & development.
Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies. The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
The show is brought to you by the team at Shares Magazine, in partnership with Cenkos Securities. The Growth and Innovation Forum connects top experts, who will share their in-depth knowledge of investing and meet directors from fast-growing and technology led London listed companies.
For 5 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal making and commercialisation.
LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
The industry’s c-suite will be joined by the sector’s most active investors, pharma and healthtech BD&L teams, key stakeholders and top tier service companies who are moving the sector forward.
This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe. Our event will again feature leading public and private companies from the pharmaceuticals, biotechnology, generics, consumer health, animal health, medical technology and healthcare services sectors.
The two-day event will include concurrent tracks of company presentations, thematic panel discussions, and 1x1/small-group meetings. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.
LSX’s Investival Showcase directly connects life science corporates to global capital. A multi-streamed showcase of early, growth stage and public life science and health technology companies, Investival Showcase provides an unrivalled opportunities to pitch, profile and connect with investors and partners brought together during the biggest week in European life science investment.
The conference, now in its 11th year, features leading speakers from the healthcare and investment communities, who will provide insight into future trends in the healthcare industry.
The audience consists of senior management from private and public companies across Europe’s life-sciences sector, as well as a number of investors and analysts from the investment community.